India's Generic Drug Producing Company
gets a Setback
08 Sep, 2005
According to the new World Trade Organization patent
protection rules that took effect on January 1, 2005 the era of
being the world's "copycat" king of generic
drug production is coming to an end for India.
No longer can Indian companies simply copy drugs
patented after January 1995. It means imitation is not going to
work any longer for the generic drug producing company of India.
In fact, it has been that way for some time for India's flagship
pharmaceutical companies such as Ranbaxy Laboratories and Dr. Reddy's
Laboratories.
They've already started spending a significant
amount in the key area of research and development, recognizing
the fact that growth will come primarily from their ability to innovate
and bring new drugs to the market.
To read more, log on to… http://edition.cnn.com/2005/WORLD/asiapcf/09/07/india.eye.pharma/
